These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8132268)

  • 21. Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.
    Murakawa M; Okamura T; Shibuya T; Harada M; Otsuka T; Niho Y
    Ann Hematol; 1992 May; 64(5):249-52. PubMed ID: 1623061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute haemorrhagic pancreatitis following L-asparaginase therapy in acute lymphoblastic leukaemia --a case report.
    Tan CL; Chiang SP; Wee KP
    Singapore Med J; 1974 Dec; 15(4):278-82. PubMed ID: 4533158
    [No Abstract]   [Full Text] [Related]  

  • 23. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
    Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
    Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute lymphoblastic leukemia in infants.
    Gürgey A; Yetgin S; Cetin M; Gümrük F; Tuncer AM; Tunçbilek E; Hiçsönmez G
    Turk J Pediatr; 2004; 46(2):115-9. PubMed ID: 15214738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin therapy in L-asparaginase-induced pancreatitis.
    Cheung YF; Lee CW; Chan CF; Chan KL; Lau YL; Yeung CY
    Med Pediatr Oncol; 1994; 22(6):421-4. PubMed ID: 7908715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia.
    Nagura E; Kimura K; Yamada K; Ota K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K
    Cancer Chemother Pharmacol; 1994; 33(5):359-65. PubMed ID: 8306408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
    Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
    Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transient diabetes mellitus with ketoacidosis in a child during the treatment of acute lymphoblastic leukemia with L-asparaginase].
    Skomra S; Przybylska T
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):31-2. PubMed ID: 1409032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Appel IM; Hop WC; Pieters R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute pancreatitis during chemotherapy of acute lymphoblastic leukaemia complicated with pseudocyst].
    Sikorska-Fic B; Stańczak E; Matysiak M; Kamiński A
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1051-5. PubMed ID: 19531825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia?
    Tokimasa S; Yamato K
    Br J Haematol; 2012 May; 157(3):381-2. PubMed ID: 22145577
    [No Abstract]   [Full Text] [Related]  

  • 33. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ureteral obstruction caused by L-asparaginase-induced pancreatitis in a child with acute lymphoblastic leukemia.
    Chen CH; Lu MY; Lin KH; Lin DT; Peng SF; Jou ST
    J Formos Med Assoc; 2004 May; 103(5):380-4. PubMed ID: 15216406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating childhood leukemia without cranial irradiation.
    Naina HV; Harris S; Patnaik MM
    N Engl J Med; 2009 Sep; 361(13):1310-1; author reply 1311-2. PubMed ID: 19780213
    [No Abstract]   [Full Text] [Related]  

  • 36. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
    Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis.
    Ridola V; Buonuomo PS; Maurizi P; Putzulu R; Annunziata ML; Pietrini D; Riccardi R
    Pediatr Blood Cancer; 2008 Feb; 50(2):378-80. PubMed ID: 16883590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epileptic seizures after octreotide administration in a 6.5-year-old female with ALL and L-asparaginase associated pancreatitis: a possible drug interaction.
    Hatzipantelis E; Pana ZD; Pavlou E; Balakou E; Tsotoulidou V; Papageorgiou T; Tragiannidis A; Athanassiadou F
    Klin Padiatr; 2011 Nov; 223(6):360-3. PubMed ID: 22052632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-asparaginase related hyperglycemia.
    Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
    Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.